Codexis, Inc. (NASDAQ:CDXS), a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the company will be participating in the following upcoming investor conferences:
JMP Securities 11 th Annual Research ConferenceDate: Monday, May 14 thTime: 8:30am PTLocation: San Francisco, CASpeaker: Peter Strumph, Interim CEO
Deutsche Bank 2012 Clean Tech, Utilities & Power ConferenceDate: Tuesday, May 15thTime: 1:35pm ETLocation: New York, NYSpeaker: Peter Strumph, Interim CEO
Webcasts and replays of the company presentations will be available in the Investor section of www.codexis.comAbout Codexis, Inc. Codexis, Inc. is a developer of cost-advantaged processes for the production of biofuels, bio-based chemicals, and pharmaceutical intermediates. Codexis' product lines include CodeXyme™ Cellulase Enzymes and CodeXol™ Detergent Alcohol. Partners and customers include global leaders such as Shell, Merck and Pfizer. For more information, see www.codexis.com.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts